Th. Corbett et al., PRECLINICAL ANTITUMOR EFFICACY OF ANALOGS OF XK469 - -[4-(7-CHLORO-2-QUINOXALINYLOXY)PHENOXY]PROPIONATE, Investigational new drugs, 16(2), 1998, pp. 129-139
A series of quinoxaline analogs of the herbicide Assure(R) was found t
o have selective cytotoxicity for solid tumors of mice in a disk-diffu
sion-soft-agar-colony-formation-assay compared to L1210 leukemia. Four
agents without selective cytotoxicity and 14 agents with selective cy
totoxicity were evaluated in vivo for activity against a solid tumor.
The four agents without selective cytotoxicity in the disk-assay were
inactive in vivo (T/C > 42%). Thirteen of the fourteen agents with sel
ectivity in the disk-assay were active in vivo (T/C < 42%). Five of th
e agents had curative activity. These five agents had a halogen (F, Cl
, Br) in the 7-position (whereas Assure(R) had a Cl in the 6 position)
. All agents with curative activity were either a carboxylic acid, or
a derivative thereof, whereas Assure(R) is the ethyl ester of the carb
oxylic acid. All other structural features were identical between Assu
re(R) and the curative agents. Assure(R) had no selective cytotoxicity
for solid tumors in the disk-assay, and was devoid of antitumor activ
ity. The analog XK469 is in clinical development.